MedTrace Logo

Using Real-world Evidence to Analyze the Clinical Effects and Adverse Events of Butylphthalide in Stroke Patients

NCT05086874 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81292

Last updated 2024-04-09

No results posted yet for this study

Summary

This is a retrospective, multi-center, real-world study. The researchers plan to include 10,000 cases of ischemic stroke patients using butylphthalide and 10,000 cases of ischemic stroke patients using Edaravone. The main purpose is to analyze the effectiveness and safety of butylphthalide and establish the drug risk assessment management plan.

Conditions

Interventions

OTHER

butylphthalide

Observational only and no predesigned interventions in this study

Sponsors & Collaborators

  • Xin Huang

    lead OTHER

Principal Investigators

  • Xin Huang · Qianfoshan Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-07
Primary Completion
2023-02-01
Completion
2023-03-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05086874 on ClinicalTrials.gov